verified SJR 0,178 · Q4 • database Scopus / SJR indexed

Australia

workspace_premium Q4 — Biotechnology lock Subscription

Journal of Commercial Biotechnology

Journal of Commercial Biotechnology is a journal indexed in SJR in Biotechnology and Economics and Econometrics with an H index of 19. It has a price of 2786 €. It has an SJR impact factor of 0,178 and it has a best quartile of Q4. It is published in English. It has an SJR impact factor of 0,178.

ISSN: 1462-8732

Category: Biotechnology

Indexation: verifiedScopus / SJR

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,178 Q4

H-index 19

Acceptance rate pie_chart

43%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.786 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR

SJR Impact

0,178

H-index

Docs (year)

139

Docs 3y

352

Total refs

4466

Cites 3y

289

Citable 3y

350

Cites/Doc 2y

0.91

Ref/Doc

32.13

Immediate OA

2786 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Biotechnology in the capital region of Europe

When should you fire the founder?

Commercializing synthetic biology: Socio-ethical concerns and challenges under intellectual property regime

Commercializing Successful Biomedical Technologies

Commercialization of innovative technologies: Bringing good ideas to the marketplace

Cloning an industry: Strategy typologies of Shanghai biotechnology companies

Chronicling the development of myozyme: The Cure and Chasing Miracles

Changing hopes and concerns about gene therapy in Japan

Can compliance help marketing and business development?

Building biotechnology teams: Personality does matter

Building biotechnology by design: Role of biotechnology in development

Building biotechnology by design: An entrepreneur's perspective

SHOW MORE ARTICLES

Building a conducive environment for life science-based entrepreneurship and industry clusters

A maturing industry: Strategic patenting trends, US and academic dominance, and the global biotechnology landscape

Biotechnology in India: Public-private partnerships

Biotechnology and the Law

Biotech funding trends: Insights from entrepreneurs and investors

Biosimilars in Brazil: developments in 2015 and business perspectives

Bioscience enterprise: Postgraduate education at Cambridge and Auckland

Bioentrepreneurship education programmes in the United States

Beyond investment: Advancing the biotechnology sector in the countries of the Gulf Cooperation Council (GCC)

Best Practices in Biotechnology Business Development

Best practices for developing university bioentrepreneurship education programmes

ATMP in practice: Towards a new industry landscape in tissue engineering

FAQs

Journal of Commercial Biotechnology has an SJR of 0,178 (best quartile Q4) in the CountryOfPapers database.

Immediate OA APC is 2786 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Journal of Commercial Biotechnology is 43%.

Journal of Commercial Biotechnology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Journal of Commercial Biotechnology?

What is the APC / publication cost?

What is the acceptance rate?